{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T04:59:55Z","timestamp":1782968395865,"version":"3.54.5"},"reference-count":0,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1205388"],"award-info":[{"award-number":["OPP1205388"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1205388"],"award-info":[{"award-number":["OPP1205388"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1205388"],"award-info":[{"award-number":["OPP1205388"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1205388"],"award-info":[{"award-number":["OPP1205388"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1205388"],"award-info":[{"award-number":["OPP1205388"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1205388"],"award-info":[{"award-number":["OPP1205388"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1205388"],"award-info":[{"award-number":["OPP1205388"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1205388"],"award-info":[{"award-number":["OPP1205388"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"TB REACH Wave 6 project of Stop TB Partnership","award":["STBP\/TBREACH\/GSA\/W6-34"],"award-info":[{"award-number":["STBP\/TBREACH\/GSA\/W6-34"]}]},{"name":"TB REACH Wave 6 project of Stop TB Partnership","award":["STBP\/TBREACH\/GSA\/W6-34"],"award-info":[{"award-number":["STBP\/TBREACH\/GSA\/W6-34"]}]},{"name":"TB REACH Wave 6 project of Stop TB Partnership","award":["STBP\/TBREACH\/GSA\/W6-34"],"award-info":[{"award-number":["STBP\/TBREACH\/GSA\/W6-34"]}]},{"name":"TB REACH Wave 6 project of Stop TB Partnership","award":["STBP\/TBREACH\/GSA\/W6-34"],"award-info":[{"award-number":["STBP\/TBREACH\/GSA\/W6-34"]}]},{"name":"TB REACH Wave 6 project of Stop TB Partnership","award":["STBP\/TBREACH\/GSA\/W6-34"],"award-info":[{"award-number":["STBP\/TBREACH\/GSA\/W6-34"]}]},{"name":"TB REACH Wave 6 project of Stop TB Partnership","award":["STBP\/TBREACH\/GSA\/W6-34"],"award-info":[{"award-number":["STBP\/TBREACH\/GSA\/W6-34"]}]},{"name":"TB REACH Wave 6 project of Stop TB Partnership","award":["STBP\/TBREACH\/GSA\/W6-34"],"award-info":[{"award-number":["STBP\/TBREACH\/GSA\/W6-34"]}]},{"name":"TB REACH Wave 6 project of Stop TB Partnership","award":["STBP\/TBREACH\/GSA\/W6-34"],"award-info":[{"award-number":["STBP\/TBREACH\/GSA\/W6-34"]}]},{"name":"South African Medical Research Council through the Strategic Health Innovation Partnerships"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Digital Adherence Technologies (DATs) are being investigated for use in many countries. In this study we evaluated the cost-effectiveness of a technology-enabled Differentiated Care Approach (DCA), where a medication monitor (Wisepill evriMED 1000 device) provided daily reminders and identified missed doses to guide SMS, phone call, and home visit interventions within the TB Monitoring Adherence to Treatment Endpoints (TB MATE) cluster-randomised trial in South Africa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a cost-effectiveness analysis from a societal perspective in one intervention clinic and one standard-of-care (SoC) clinic in each of three selected provinces between June 2019 and August 2020. Health system costs were collected using a bottom-up activity-based costing approach involving time and motion studies. People with Tuberculosis (PWTB) were interviewed on costs related to accessing the intervention. The primary efficacy outcome used in the trial was proportion of patients with \u2265\u200980% adherence, measured using medication monitor opening as a proxy for adherence. Unit costs were calculated as cost per patient treated for TB while incremental cost-effectiveness ratio (ICER) was calculated as cost per additional adherent PWTB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From a total of 2757 enrolled (62% male, median age 36 years IQR (27\u201345 years), adherence data was available for 1306 PWTB in the intervention arm and 1278 PWTB in the SoC arm, where effectiveness was 81% and 50.8% in the intervention and SoC arms respectively. The total cost per patient treated for TB was $103.93-$199.87 (intervention) and $44.89 - $131.22 (SoC), resulting in a societal incremental cost of $49.73 (mean). Patient costs were $38.98 - $117.94 (intervention) and $35.92-$91.94 (SoC) per patient with indirect costs (foregone income) contributing to a large proportion of total costs at three intervention (56.7% \u2212\u200969.8%) and two SoC (69% and 77.4%) clinics. The ICER of achieving an additional adherent PWTB was $166.33.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Medication monitors and DCA can be considered a cost-effective option for investment and scale-up if we reduce health systems costs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-026-28361-6","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:53:33Z","timestamp":1782964413000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cost-effectiveness analysis of implementing a medication monitor and differentiated care approach among people with TB in South Africa"],"prefix":"10.1186","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4304-1729","authenticated-orcid":false,"given":"Rachel","family":"Mukora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Resignation","family":"Pelusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriah","family":"Maraba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Orrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pren","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavindhran","family":"Velen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Fielding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dowdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedona","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salome","family":"Charalambous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-28361-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:53:34Z","timestamp":1782964414000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-28361-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":0,"alternative-id":["28361"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-28361-6","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was structured in accordance with the Declaration of Helsinki which deals with the recommendations guiding doctors in biomedical research involving human participants. The parent study received ethics approval from the three district and provincial ethics committees where the trial sites were located. This costing study was approved by the Human Research Ethics Committee (HREC) of the University of Witwatersrand (Ref 180705) and the University of Cape Town (Ref 452\/2018), as well as, from the London School of Hygiene & Tropical Medicine (Ref 16107). We obtained written informed consent for study participation from all participants. Participants were not reimbursed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}